1. Home
  2. EVO vs ARMN Comparison

EVO vs ARMN Comparison

Compare EVO & ARMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • ARMN
  • Stock Information
  • Founded
  • EVO 1993
  • ARMN 1992
  • Country
  • EVO Germany
  • ARMN Canada
  • Employees
  • EVO N/A
  • ARMN N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • ARMN
  • Sector
  • EVO Health Care
  • ARMN
  • Exchange
  • EVO Nasdaq
  • ARMN Nasdaq
  • Market Cap
  • EVO 1.2B
  • ARMN 1.4B
  • IPO Year
  • EVO 2021
  • ARMN N/A
  • Fundamental
  • Price
  • EVO $3.48
  • ARMN $9.29
  • Analyst Decision
  • EVO Buy
  • ARMN Strong Buy
  • Analyst Count
  • EVO 2
  • ARMN 1
  • Target Price
  • EVO $5.40
  • ARMN $17.00
  • AVG Volume (30 Days)
  • EVO 52.1K
  • ARMN 1.9M
  • Earning Date
  • EVO 11-05-2025
  • ARMN 08-07-2025
  • Dividend Yield
  • EVO N/A
  • ARMN N/A
  • EPS Growth
  • EVO N/A
  • ARMN N/A
  • EPS
  • EVO N/A
  • ARMN 0.02
  • Revenue
  • EVO $912,894,891.00
  • ARMN $646,783,000.00
  • Revenue This Year
  • EVO $0.43
  • ARMN $49.45
  • Revenue Next Year
  • EVO $9.72
  • ARMN $8.15
  • P/E Ratio
  • EVO N/A
  • ARMN $365.59
  • Revenue Growth
  • EVO N/A
  • ARMN 38.72
  • 52 Week Low
  • EVO $2.84
  • ARMN $3.29
  • 52 Week High
  • EVO $5.64
  • ARMN $9.58
  • Technical
  • Relative Strength Index (RSI)
  • EVO 39.62
  • ARMN 76.18
  • Support Level
  • EVO $3.36
  • ARMN $6.70
  • Resistance Level
  • EVO $3.52
  • ARMN $9.58
  • Average True Range (ATR)
  • EVO 0.08
  • ARMN 0.37
  • MACD
  • EVO 0.00
  • ARMN 0.19
  • Stochastic Oscillator
  • EVO 31.58
  • ARMN 89.95

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About ARMN Aris Mining Corporation

Aris Mining Corp is engaged in the acquisition, exploration, development, and operation of gold properties in Colombia, Guyana, and Canada. It owns and operates its Segovia Operations, Soto Norte Project and Marmato Mine in Colombia, the Toroparu Project in Guyana, and the Juby Project in Ontario, Canada. The company generates revenue from the sale of gold and silver.

Share on Social Networks: